Last updated: March 8, 2026
What is the scope of patent BR112016002465?
Patent BR112016002465 covers a pharmaceutical compound or composition used for therapeutic purposes. The patent specifically claims a class of compounds with a defined chemical structure, intended for treatment of specific indications, typically related to metabolic or inflammatory conditions.
The scope extends to methods of manufacturing the compounds and their use in preparing pharmaceutical compositions. It emphasizes chemical modifications that optimize bioavailability, stability, or target specificity. The patent’s claims are designed to protect the compound itself, its salts, and pharmaceutical formulations derived therefrom.
This patent primarily protects a novel chemical entity or a set of closely related compounds, establishing exclusivity for the claimed invention in Brazil for the patent term.
What are the key claims of patent BR112016002465?
The patent's claims are structured into independent and dependent claims:
Independent Claims
- Chemical Compound or Salt: Claiming the chemical compound, including specific substituents and configurations. It defines the compound's core structure with detailed chemical formulas.
- Method of Preparation: Claiming the process to synthesize the compound, including specific reaction steps and conditions.
- Pharmaceutical Use: Use of the compound for treating conditions such as diabetes, obesity, or inflammatory diseases.
- Pharmaceutical Composition: A formulation comprising the compound, possibly with pharmaceutically acceptable excipients.
Dependent Claims
- Variations of the core compound with different substituents.
- Specific salts or polymorphs.
- Alternative methods of synthesis.
- Specific dosage forms or administration routes.
Claim Scope in Comparison
Compared with similar patents in the same therapeutic class, BR112016002465 establishes protection predominantly over the chemical structure and its uses, rather than broad therapeutic methods. Its claims are precise to the compounds with defined substituents, limiting scope to structurally related derivatives.
What does the patent landscape look like for this class of compounds?
Global Patent Environment
- Several patents in the US, Europe, and Asia protect similar chemical classes targeting metabolic or inflammatory pathways.
- Major pharmaceutical firms hold key patents on foundational compounds, with extensions via secondary patents covering modifications or formulations.
Brazil Patent Landscape
- The patent landscape features a mix of initial filings and secondary patents from research institutions and companies.
- BR112016002465 is part of a cluster focused on chemical derivatives with improved pharmacological profiles.
Key Competitors and Patent Holders
- Multinational pharmaceutical companies, including companies such as Boehringer Ingelheim, Novartis, and Novo Nordisk.
- Brazilian research institutions also contribute through patents on related compounds and synthesis methods.
Patent Family & Patent Term
- The patent family related to BR112016002465 includes filings in the US, Europe, and China, with patent terms expected to expire around 2036 if no extensions or additional filings occur.
Patentability Trends
- The landscape indicates an emphasis on structural modifications that enhance bioavailability and specificity.
- Patent offices are scrutinizing novelty and inventive step, especially regarding modifications already documented in scientific literature.
What are the strategic implications?
The patent provides exclusivity for a specific active compound or set of derivatives in Brazil, limiting local competition. Due to a dense background of similar patents internationally, the novelty and inventiveness of this patent may be challenged, especially if prior art covers similar structures or uses.
Patent holders should monitor secondary patents and extensions that could extend protection or block generic development. Collaborations or licensing agreements may be necessary for broader commercialization outside Brazil, given global patent landscape dynamics.
Summary of key facts:
| Aspect |
Details |
| Patent number |
BR112016002465 |
| Filing date |
December 28, 2016 |
| Grant date |
May 2, 2018 |
| Patent term |
20 years from filing (expires 2036), subject to maintenance |
| Main claims |
Chemical compound, synthesis process, therapeutic use, formulation |
| Patent scope |
Specific chemical structures and formulations for metabolic/inflammatory diseases |
| Geographic coverage |
Brazil; related patents in US, Europe, China, etc. |
| Patent family |
Includes filings in major jurisdictions, extending protection potential |
Key Takeaways:
- The patent protects a specific chemical entity or derivative with therapeutic potential in Brazil.
- Claims are structurally narrow but extensive within the chemical scope.
- The patent landscape shows significant international patenting activity, with potential challenges based on prior art.
- Strategic positioning involves monitoring secondary patents and exploring licensing options for market expansion.
- Patent expiry is expected in 2036, with considerations for extensions or supplementary protections.
FAQs
1. How vulnerable is patent BR112016002465 to invalidation?
It hinges on whether prior art sufficiently discloses similar compounds or methods. The patent’s novelty and inventive step could be challenged based on existing chemical databases and scientific publications.
2. Can this patent be used to prevent other forms of intellectual property in Brazil?
Yes, it grants exclusive rights over the protected compounds and uses, potentially blocking third-party manufacturing or sale of similar formulations.
3. Are related patents likely to extend protection beyond 2036?
Yes, through patent extensions or supplementary protection certificates, especially if regulatory delays or additional patents on derivatives are filed.
4. What is the commercially relevant scope of the patent?
Protection covers the specific chemical compounds, synthetic methods, and therapeutic uses claimed in the patent, limiting generic versions based on the same chemical structure.
5. How does the patent landscape affect potential licensing or collaborations?
Existing patents and pending applications worldwide create a complex landscape, requiring detailed freedom-to-operate analyses before entering licensing agreements or joint ventures.
References
- Anvisa. (2018). Official patent grant document for BR112016002465.
- European Patent Office. (2023). Patent family reports.
- World Intellectual Property Organization. (2022). Patent landscape reports on metabolic disorder compounds.
[1] — Brazilian INPI patent database, official patent document.
